Price $4.45 |
Market Cap
27.8M
|
Sector Capital Goods |
Div. Growth
-100.00%
|
P/E
-
|
P/B
0.9
|
P/S
0.71
|
Dividend %
-
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-1.8K
|
FCF
-1.7
|
Op. Margin
-4.10%
|
Net Margin
-8.90%
|
ROE
-11.00%
|
ROI
-1.10%
|
ROA
-3.50%
|
EPS Growth
-
|
Current Ratio
2.8
|
Debt/Equity
20.30%
|
Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
---|---|---|---|---|---|
Nephros, Inc. (NEPH) | $2.19 | - | - | 16.9M | Strong Buy |
TSS Inc (TSSI) | $0.81 | - | - | 8.5M | Strong Buy |
Proto Labs Inc (PRLB) | $31.42 | - | - | 634.1M | Strong Buy |
Hydrofarm Holdings Group Inc (HYFM) | $0.85 | - | - | 44.6M | Strong Buy |
IGC Pharma Inc (IGC) | $0.43 | - | - | 19.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More